← All companies

AZTR

Azitra, Inc.

AZTR NYSE Pharmaceutical Preparations EDGAR ↗

$0.13

+0.00 +1.15%

Key statistics

from XBRL data in SEC filings

Market cap

$2.15M

Revenue (TTM)

$0.00

Net income (TTM)

-$11.8M

EPS (TTM)

$-0.95

P/E ratio

—

Dividend yield

—

Free cash flow

-$11.2M

Cash

$10.1M

Total assets

$12.1M

Gross margin

—

52-week range

$0.10 – $1.40

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jul 15, 2026 8-K Other events Jun 17, 2026 8-K Amended charter or bylaws; Shareholder vote results Jun 16, 2026 8-K Other events Jun 4, 2026 8-K Other events May 27, 2026 8-K Results of operations (earnings release) May 13, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Other events Mar 23, 2026 8-K Delisting notice or listing-rule failure; Other events Mar 13, 2026 8-K Other events Mar 5, 2026 8-K Results of operations (earnings release) Feb 27, 2026 10-K Fiscal year ended 2025-12-31 Feb 27, 2026 8-K Other events Feb 6, 2026 8-K Delisting notice or listing-rule failure; Other events Dec 17, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Nov 25, 2025 8-K Results of operations (earnings release) Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Delisting notice or listing-rule failure; Other events Oct 3, 2025 8-K Entered a material agreement Aug 29, 2025 8-K Modified rights of security holders; Amended charter or bylaws Aug 20, 2025 8-K Results of operations (earnings release) Aug 11, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Amended charter or bylaws; Shareholder vote results Jul 3, 2025 8-K Shareholder vote results Jun 23, 2025 8-K Other events Jun 18, 2025 8-K Regulation FD disclosure Jun 17, 2025 8-K Results of operations (earnings release) May 13, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Item 5.08 May 2, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Apr 24, 2025 8-K Results of operations (earnings release) Feb 24, 2025 10-K Fiscal year ended 2024-12-31 Feb 24, 2025 8-K Shareholder vote results Feb 20, 2025 8-K Entered a material agreement; Unregistered sale of equity Feb 6, 2025 8-K Entered a material agreement; Other events Feb 6, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jan 16, 2025 8-K Shareholder vote results Nov 26, 2024 8-K Results of operations (earnings release) Nov 13, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Aug 12, 2024